Julie Schmittdiel to Retrospective Studies
This is a "connection" page, showing publications Julie Schmittdiel has written about Retrospective Studies.
Connection Strength
1.728
-
Identifying Predictors of Homelessness Among Adults in a Large Integrated Health System in Northern California. Perm J. 2023 03 15; 27(1):56-71.
Score: 0.132
-
Incidence and Medical Hospitalization Rates of Patients With Pediatric Eating Disorders. Perm J. 2022 12 19; 26(4):56-61.
Score: 0.130
-
Address Changes Are Associated With Unmet Glycemic Targets: Opportunities to Improve Processes and Outcomes of Care Among People With Type 2 Diabetes. Perm J. 2022 06 29; 26(2):1-10.
Score: 0.126
-
Prior Immunosuppressive Therapy and Severe Illness Among Patients Diagnosed with SARS-CoV-2: a Community-Based Study. J Gen Intern Med. 2021 12; 36(12):3794-3801.
Score: 0.120
-
Racial and Ethnic Disparities in Diabetes Care Quality among Women of Reproductive Age in an Integrated Delivery System. Womens Health Issues. 2020 May - Jun; 30(3):191-199.
Score: 0.108
-
Comorbid Diabetes and Severe Mental Illness: Outcomes in an Integrated Health Care Delivery System. J Gen Intern Med. 2020 01; 35(1):160-166.
Score: 0.105
-
Identifying Common Predictors of Multiple Adverse Outcomes Among Elderly Adults With Type-2 Diabetes. Med Care. 2019 09; 57(9):702-709.
Score: 0.104
-
Relationships between Medication Adherence and Cardiovascular Disease Risk Factor Control in Elderly Patients with Diabetes. Pharmacotherapy. 2017 Oct; 37(10):1204-1214.
Score: 0.090
-
Opportunities to Reduce Diabetes Risk in Women of Reproductive Age: Assessment and Treatment of Prediabetes within a Large Integrated Delivery System. Womens Health Issues. 2017 Nov - Dec; 27(6):666-672.
Score: 0.089
-
Telephone-Based Coaching. Am J Health Promot. 2017 03; 31(2):136-142.
Score: 0.085
-
Prescription medication burden in patients with newly diagnosed diabetes: a SUrveillance, PREvention, and ManagEment of Diabetes Mellitus (SUPREME-DM) study. J Am Pharm Assoc (2003). 2014 Jul-Aug; 54(4):374-82.
Score: 0.072
-
Initial persistence with antihypertensive therapies is associated with depression treatment persistence, but not depression. J Clin Hypertens (Greenwich). 2014 Jun; 16(6):412-7.
Score: 0.071
-
Health system factors and antihypertensive adherence in a racially and ethnically diverse cohort of new users. JAMA Intern Med. 2013 Jan 14; 173(1):54-61.
Score: 0.065
-
The comparative effectiveness of mail order pharmacy use vs. local pharmacy use on LDL-C control in new statin users. J Gen Intern Med. 2011 Dec; 26(12):1396-402.
Score: 0.059
-
Association of Cardiovascular Outcomes and Mortality With Sustained Long-Acting Insulin Only vs Long-Acting Plus Short-Acting Insulin Treatment. JAMA Netw Open. 2021 09 01; 4(9):e2126605.
Score: 0.030
-
Incidence of 30-Day Venous Thromboembolism in Adults Tested for SARS-CoV-2 Infection in an Integrated Health Care System in Northern California. JAMA Intern Med. 2021 07 01; 181(7):997-1000.
Score: 0.029
-
SARS-CoV-2 Clinical Outcomes in Patients with Cancer in a Large Integrated Health Care System in Northern California. Oncologist. 2021 03; 26(3):e500-e504.
Score: 0.028
-
Smoking cessation treatment for individuals with comorbid diabetes and serious mental illness in an integrated health care delivery system. Addict Behav. 2021 03; 114:106697.
Score: 0.028
-
Predictors of Hyperkalemia and Hypokalemia in Individuals with Diabetes: a Classification and Regression Tree Analysis. J Gen Intern Med. 2020 08; 35(8):2321-2328.
Score: 0.027
-
Comparison of Mortality and Major Cardiovascular Events Among Adults With Type 2 Diabetes Using Human vs Analogue Insulins. JAMA Netw Open. 2020 01 03; 3(1):e1918554.
Score: 0.027
-
The Relationship Between Prescription Copayments and Contraceptive Adherence in a New-user Cohort. Med Care. 2018 07; 56(7):577-582.
Score: 0.024
-
Medication Adherence Does Not Explain Black-White Differences in Cardiometabolic Risk Factor Control among Insured Patients with Diabetes. J Gen Intern Med. 2016 Feb; 31(2):188-195.
Score: 0.020
-
Determinants of adherence to diabetes medications: findings from a large pharmacy claims database. Diabetes Care. 2015 Apr; 38(4):604-9.
Score: 0.019
-
High-dimensional propensity score algorithm in comparative effectiveness research with time-varying interventions. Stat Med. 2015 Feb 28; 34(5):753-81.
Score: 0.019
-
Implications of different laboratory-based incident diabetic kidney disease definitions on comparative effectiveness studies. J Comp Eff Res. 2014 Jul; 3(4):359-69.
Score: 0.018
-
Intensification of antihyperglycemic therapy among patients with incident diabetes: a Surveillance Prevention and Management of Diabetes Mellitus (SUPREME-DM) study. Pharmacoepidemiol Drug Saf. 2014 Jul; 23(7):699-710.
Score: 0.018
-
Initial antihyperglycemic drug therapy among 241 327 adults with newly identified diabetes from 2005 through 2010: a surveillance, prevention, and management of diabetes mellitus (SUPREME-DM) study. Ann Pharmacother. 2013 Oct; 47(10):1280-91.
Score: 0.017
-
Characteristics of diabetic patients associated with achieving and maintaining blood pressure targets in the Adherence and Intensification of Medications program. Chronic Illn. 2014 Mar; 10(1):60-73.
Score: 0.017
-
Benefits of early hypertension control on cardiovascular outcomes in patients with diabetes. Diabetes Care. 2013 Feb; 36(2):322-7.
Score: 0.016
-
The association between medication adherence and treatment intensification with blood pressure control in resistant hypertension. Hypertension. 2012 Aug; 60(2):303-9.
Score: 0.016
-
When more is not better: treatment intensification among hypertensive patients with poor medication adherence. Circulation. 2008 Jun 03; 117(22):2884-92.
Score: 0.012
-
The impact of aging and chronic disease on use of hospital and outpatient services in a large HMO: 1971-1991. J Am Geriatr Soc. 1997 Jun; 45(6):667-74.
Score: 0.006